NCT04839250

Brief Summary

To evaluate the differences between three-Dimensional heads-Up surgery system and traditional surgery methods of cataract surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 4, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 9, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2021

Completed
Last Updated

May 12, 2022

Status Verified

May 1, 2022

Enrollment Period

9 months

First QC Date

April 4, 2021

Last Update Submit

May 7, 2022

Conditions

Keywords

three-dimensional surgerymicrosurgeryphacoemulsification

Outcome Measures

Primary Outcomes (2)

  • change of corneal incision from 1day after surgery to 1 months

    the shape and length of the corneal incision ,if descemet's layer detachment happens

    up to 1day,1week,1 month

  • corneal endothelial cell density

    the number of corneal endothelial cells per unit area

    up to 1 month

Secondary Outcomes (3)

  • best corrected visual acuity

    up to 1 month

  • change from baseline central corneal thickness at 1 months

    up to 1 day,1 week,1 month

  • change from baseline corneal incision thickness at 1 months

    up to 1 day,1 week,1 month

Study Arms (2)

cataract surgery performed by heads-up method

EXPERIMENTAL

3D heads-up surgery was performed under the NGENUITY® 3D visualization system

Procedure: heads-up method

Traditional surgery

NO INTERVENTION

Traditional surgery was performed under a surgical microscope.

Interventions

3D surgical video system, which includes Alcon NGENUITY 3D visualization system (Alcon, Fort Worth, TX) and Leica M822 and M844 microscopes (Leica Microsystems, Wetzlar, Germany),can be used to perform head-up phacoemulsification combined with intraocular lens implantation surgery.

cataract surgery performed by heads-up method

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnose age-related cataract;
  • Plan to perform phacoemulsification of cataract with intraocular lens implantation;
  • Willing to cooperate with the re-examination of 1 day, 1 week, and 1 month after surgery;
  • Able to understand and independently fill in the informed consent form and postoperative follow-up plan.

You may not qualify if:

  • Cataract caused by other reasons;
  • Fundus diseases such as severe diabetic retinopathy, high myopic retinopathy or macular degeneration;
  • Corneal diseases, corneal endothelial cells \<1800/mm2;
  • Small palpebral fissure;
  • Those with a history of glaucoma, uveitis, eye trauma or eye surgery;
  • Those who cannot cooperate with the inspection and have not completed the one-month follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eye Hospital of Wenzhou Medical College

Wenzhou, Zhejiang, China

Location

Related Publications (1)

  • Zhu Z, Chang P, Huang F, Shen S, Zhao X, Ji X, Zhao YE. Comparison of Three-Dimensional Surgical System Versus Binocular Microscope for Clear Corneal Incision in Cataract Surgery. Ophthalmol Ther. 2022 Aug;11(4):1589-1600. doi: 10.1007/s40123-022-00537-4. Epub 2022 Jun 24.

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice president of Eye Hospital of Wenzhou Medical University, Wenzhou Medical University

Study Record Dates

First Submitted

April 4, 2021

First Posted

April 9, 2021

Study Start

February 1, 2021

Primary Completion

October 31, 2021

Study Completion

October 31, 2021

Last Updated

May 12, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations